Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab versus adalimumab monotherapy in rheumatoid arthritis
2009-015845-21Phase 4Completed
- Sponsor
- Roche
- Start
- Mar 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Tocilizumab arm with Adalimumab arm (2 arms). Primary endpoint: Change in DAS28 from baseline to Week 24. Started Mar 2010; status: completed.
02
Drugs
tocilizumabadalimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-015845-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015845-21.